Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ulrich Storz

Ulrich Storz

Michalski Hüttermann & Partner, Germany

Title: How AbbVie tries to fend off world’s blockbuster No 1 from generic competition

Biography

Biography: Ulrich Storz

Abstract

This presentation discusses the patent strategy underlying the world’s best selling drug, AbbVie’s Humira®. Despite a non-optimal starting position, AbbVie has established an extensive portfolio to fend off biosimilar competition. The presentation will discuss this portfolio in detail, and comment on its strengths and weaknesses.